How big is the Clinical Data Analytics Market?

The Clinical Data Analytics Market size is expected to reach USD 81.64 billion in 2024 and grow at a CAGR of 27.53% to reach USD 24.21 billion by 2029. Read More

What is the current Clinical Data Analytics Market size?

In 2024, the Clinical Data Analytics Market size is expected to reach USD 81.64 billion. Read More

Who are the key players in Clinical Data Analytics Market?

IBM Corporation, Oracle Corporation, Inspirata Inc., Allscripts Healthcare, LLC and SAS Institute, Inc. are the major companies operating in the Clinical Data Analytics Market. Read More

Which is the fastest growing region in Clinical Data Analytics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Clinical Data Analytics Market?

In 2024, the North America accounts for the largest market share in Clinical Data Analytics Market. Read More

What years does this Clinical Data Analytics Market cover, and what was the market size in 2023?

In 2023, the Clinical Data Analytics Market size was estimated at USD 59.16 billion. The report covers the Clinical Data Analytics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Clinical Data Analytics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Clinical Data Analytics Market

Clinical Data Analytics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Clinical Data Analytics Market Report is Segmented by Deployment Model (Cloud and On-Premise), Application (Quality Improvement and Clinical Benchmarking, Clinical Decision Support, Regulatory Reporting and Compliance, Comparative Analytics/Comparative Effectiveness, and Precision Health), End-User Vertical (Payers and Providers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America). The Market Sizes and Forecasts are Provided in Terms of Value (USD) for all the Above Segments.

Clinical Data Analytics Industry Overview

The clinical data analytics market is semi-consolidated and has gained a competitive edge in recent years. In terms of market share, a few significant players currently dominate the market. These market leaders are focusing on expanding their customer base in foreign countries. These businesses leverage strategic collaborative initiatives to increase their market share and profitability.

July 2024 - EQT announced that the EQT Healthcare Growth Strategy and the EQT Growth Fund had reached an agreement to purchase a controlling interest in CluePoints. CluePoints is a cloud-based software platform for Risk-Based Quality Management (“RBQM”) and data quality oversight in clinical trials, aimed at facilitating safer and more effective processes and enhancing data integrity and risk compliance. This recent investment arrives as CluePoints experiences rapid growth, supported by the rising utilization of RBQM software in nearly all clinical trial stages.
October 2023 – Holmusk and Veradigm announced a new phase of strategic investment to fuel innovation and close the evidence gap in behavioral health. The collaboration seeks to draw on the strengths of each company to fuel innovation in behavioral health and create the evidence needed to move the field forward. In this new phase of the collaboration, cohorts of millions of behavioral health patients and related de-identified clinical data from Veradigm will be added to Holmusk’s NeuroBlu Database, a leading source for real-world data that shows how behavioral health care is delivered.